Cysteine

serpin family C member 1 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30431449 Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy. 2019 Jan 1
2 18206177 Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine. 2008 Feb 13 3
3 9521646 Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. 1998 Mar 10 2
4 8874869 A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis. 1996 Jul 1
5 7512382 Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region. 1994 Apr 12 1
6 8037658 Interaction of heparin with synthetic antithrombin III peptide analogues. 1994 Jul 1 1
7 8176841 [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells]. 1994 Apr 1
8 8357789 Transmission of conformational change from the heparin binding site to the reactive center of antithrombin. 1993 Aug 24 1
9 8376590 Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. 1993 Sep 1
10 1546950 The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin. 1992 Mar 1 3
11 2390061 Re-formation of disulphide bonds in reduced antithrombin III. 1990 Aug 1 24
12 6830263 Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation. 1983 Feb 15 3